Canadian Public Health Association

The Canadian Public Health Association (CPHA) is a non-governmental organization (NGO) that “advises[s] decision-makers about public health system reform and to guide initiatives to help safeguard the personal and community health of Canadians and people around the world.”1)

Academic Journal

The CPHA publishes the Canadian Journal of Public Health, which “aims to advance public health research and practice in Canada and around the world, contributing to the improvement of the health of populations and the reduction of health inequalities.”2) Its Editor-in-Chief is Louise Potvin. The Journal is a member of the Committee on Publication Ethics (COPE).3)

In its 2020 Annual Report, the CPHA reported revenue from the journal of $89,799.00 and expenses of $76,339.00, for a profit of $13,460.00.4) It made an additional $30,905.00 in revenue from Publication Sales with $25,770.00 in expenses, for a profit of $5,135.00. If these two are combined, the journal made a net profit of $18,595.00 in 2020.

Funding and Partnerships

Despite claims of independence, the CPHA is funded by groups that cause substantial potentical conflicts of interest including pharmaceutical companies, government agencies, and academic institutions.5) 6) 7) 8) 9) 10) 11) 12) 13) 14)

Academia

The CPHA receives funding from the following academic institutions:

Government

Federal

The CPHA receives funding from their “benefactors” in the Canadian federal government through the following funding bodies:

In its 2020 Annual Report, the CPHA reported receiving $518,471.00 from the Canada Emergency Wage Subsidy fund.

Provincial

Alberta
British Columbia
Ontario
Québec

Regional

Alberta
British Columbia

Healthcare

Insurance Companies

Non-Governmental Organizations (NGOs)

Pharmaceutical Companies

The CPHA receives financial support from all of the major pharmaceutical companies with a stake in the COVID-19 crisis, either directly or through aggregates:

Supra-national Organizations

Some funding for the CPHA comes from outside Canada's borders from international interests:

Projects and Conferences

In its 2020 Annual report, the CPHA revealed that its revenue and expenses related to “Projects and Conferences” was identical at $2,924,754.00, for a net profit of $0.

CANVax

The CPHA funds a project called The Canadian Vaccination Evidence Resource and Exchange Centre (CANVax), an “online database of curated resources to support immunization program planning and promotional activities to improve vaccine acceptance and uptake in Canada.”24)

1)
Canadian Public Health Association. Vision and mission. Retrieved December 6, 2021, from https://www.cpha.ca/vision-and-mission
2)
Springer. Canadian Journal of Public Health. Retrieved December 6, 2021, from https://www.springer.com/journal/41997?error=cookies_not_supported&code=dd01f1b5-c4f8-489c-bd9c-7ca01b9e6685
4)
Canadian Public Health Association. 2020 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/uploads/about/reports/2020-annual-report-e.pdf
5)
Canadian Public Health Association. Corporate partners. Retrieved December 6, 2021, from https://www.cpha.ca/corporate-partners
6)
Canadian Public Health Association. 2019 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/uploads/about/reports/2019-annual-report-web-e.pdf
7)
Canadian Public Health Association. 2018 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/uploads/about/reports/2018-annual-report-web-e.pdf
8)
Canadian Public Health Association. 2017 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/uploads/about/bod/2017-AR-web_e.pdf
9)
Canadian Public Health Association. 2016 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2016_ar_e.pdf
10)
Canadian Public Health Association. 2015 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2015_ar_e.pdf
11)
Canadian Public Health Association. 2014 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2014_ar_e.pdf
12)
Canadian Public Health Association. 2013 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2013_ar_e.pdf
13)
Canadian Public Health Association. 2012 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2012_ar_e.pdf
14)
Canadian Public Health Association. 2010 Annual Report. Retrieved December 6, 2021, from https://www.cpha.ca/sites/default/files/assets/annual-reports/2010_ar_e.pdf
15)
BIOTECanada. (2021, October 15). Canada’s Vaccine Industry Committee. Retrieved December 6, 2021, from http://www.biotech.ca/policy-matters/health/canadas-vaccine-industry-committee/
16)
Bachelot-Fontaine, L., Arndt, N., Cole, D., & Pinzolits, T. (2020, April 22). Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19. Valneva. Retrieved December 6, 2021, from https://valneva.com/press-release/valneva-and-dynavax-announce-collaboration-to-advance-vaccine-development-for-covid-19/
17)
Innovative Medicines Canada. Member Companies. Retrieved November 2, 2021, from http://innovativemedicines.ca/about/member-companies/
18)
Anderson, N. (2021, March 9). CEPI and VBI Vaccines Collaborate to Advance Vaccine Candidates Against COVID-19 Variants. VBI Vaccines. Retrieved November 24, 2021, from https://www.vbivaccines.com/press-releases/cepi-collaboration/
19)
Anderson, N. (2021, September 29). VBI Vaccines Announces New Preclinical Data and Initiation of VBI-2905 Clinical Study Targeting Broadened Immunity Against COVID-19 and Variants of Concern. VBI Vaccines. Retrieved November 24, 2021, from https://www.vbivaccines.com/press-releases/initiation-of-vbi-2905-clinical-study/
20)
Coalition for Epidemic Preparedness Innovations (CEPI). (2021, November 4). CEPI announces first funding awards in quest to develop ‘variant-proof’ COVID-19 vaccines. Retrieved December 6, 2021, from https://cepi.net/news_cepi/cepi-announces-first-funding-awards-in-quest-to-develop-variant-proof-covid-19-vaccines/
21)
Brusky, T. (2021, November 4). CEPI awards USask’s VIDO $6M for vaccine development. Vaccine and Infectious Disease Organization. Retrieved December 6, 2021, from https://www.vido.org/news/cepi
22)
South China Vaccine Corporation. ABOUT US. Retrieved December 6, 2021, from http://www.gdscvc.com/about
23)
Vaccine and Infectious Disease Organization (VIDO). Annual Report 2019–2020. Retrieved December 6, 2021, from https://www.vido.org/assets/upload/pdf/annual_reports/VIDO - Annual Report 2019-2020.pdf
24)
About CANVax. Retrieved December 10, 2021, from https://www.canvax.ca/about-canvax
Print/export